Tomas G Neilan1, Francois-Pierre Mongeon2, Ravi V Shah1, Otavio Coelho-Filho3, Siddique A Abbasi4, John A Dodson5, Ciaran J McMullan6, Bobak Heydari4, Gregory F Michaud4, Roy M John4, Ron Blankstein4, Michael Jerosch-Herold7, Raymond Y Kwong8. 1. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Division of Cardiology, Department of Medicine, Cardiac MR PET CT Program, Division of Radiology, Massachusetts General Hospital, Boston, Massachusetts. 2. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada. 3. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Internal Medicine, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil. 4. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 5. Division of Aging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 6. Division of Nephrology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 7. Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 8. Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: rykwong@partners.org.
Abstract
OBJECTIVES: This study tested whether myocardial extracellular volume (ECV) is increased in patients with hypertension and atrial fibrillation (AF) undergoing pulmonary vein isolation and whether there is an association between ECV and post-procedural recurrence of AF. BACKGROUND: Hypertension is associated with myocardial fibrosis, an increase in ECV, and AF. Data linking these findings are limited. T1 measurements pre-contrast and post-contrast in a cardiac magnetic resonance (CMR) study provide a method for quantification of ECV. METHODS: Consecutive patients with hypertension and recurrent AF referred for pulmonary vein isolation underwent a contrast CMR study with measurement of ECV and were followed up prospectively for a median of 18 months. The endpoint of interest was late recurrence of AF. RESULTS: Patients had elevated left ventricular (LV) volumes, LV mass, left atrial volumes, and increased ECV (patients with AF, 0.34 ± 0.03; healthy control patients, 0.29 ± 0.03; p < 0.001). There were positive associations between ECV and left atrial volume (r = 0.46, p < 0.01) and LV mass and a negative association between ECV and diastolic function (early mitral annular relaxation [E'], r = -0.55, p < 0.001). In the best overall multivariable model, ECV was the strongest predictor of the primary outcome of recurrent AF (hazard ratio: 1.29; 95% confidence interval: 1.15 to 1.44; p < 0.0001) and the secondary composite outcome of recurrent AF, heart failure admission, and death (hazard ratio: 1.35; 95% confidence interval: 1.21 to 1.51; p < 0.0001). Each 10% increase in ECV was associated with a 29% increased risk of recurrent AF. CONCLUSIONS: In patients with AF and hypertension, expansion of ECV is associated with diastolic function and left atrial remodeling and is a strong independent predictor of recurrent AF post-pulmonary vein isolation.
OBJECTIVES: This study tested whether myocardial extracellular volume (ECV) is increased in patients with hypertension and atrial fibrillation (AF) undergoing pulmonary vein isolation and whether there is an association between ECV and post-procedural recurrence of AF. BACKGROUND:Hypertension is associated with myocardial fibrosis, an increase in ECV, and AF. Data linking these findings are limited. T1 measurements pre-contrast and post-contrast in a cardiac magnetic resonance (CMR) study provide a method for quantification of ECV. METHODS: Consecutive patients with hypertension and recurrent AF referred for pulmonary vein isolation underwent a contrast CMR study with measurement of ECV and were followed up prospectively for a median of 18 months. The endpoint of interest was late recurrence of AF. RESULTS:Patients had elevated left ventricular (LV) volumes, LV mass, left atrial volumes, and increased ECV (patients with AF, 0.34 ± 0.03; healthy control patients, 0.29 ± 0.03; p < 0.001). There were positive associations between ECV and left atrial volume (r = 0.46, p < 0.01) and LV mass and a negative association between ECV and diastolic function (early mitral annular relaxation [E'], r = -0.55, p < 0.001). In the best overall multivariable model, ECV was the strongest predictor of the primary outcome of recurrent AF (hazard ratio: 1.29; 95% confidence interval: 1.15 to 1.44; p < 0.0001) and the secondary composite outcome of recurrent AF, heart failure admission, and death (hazard ratio: 1.35; 95% confidence interval: 1.21 to 1.51; p < 0.0001). Each 10% increase in ECV was associated with a 29% increased risk of recurrent AF. CONCLUSIONS: In patients with AF and hypertension, expansion of ECV is associated with diastolic function and left atrial remodeling and is a strong independent predictor of recurrent AF post-pulmonary vein isolation.
Authors: Martin Ugander; Abiola J Oki; Li-Yueh Hsu; Peter Kellman; Andreas Greiser; Anthony H Aletras; Christopher T Sibley; Marcus Y Chen; W Patricia Bandettini; Andrew E Arai Journal: Eur Heart J Date: 2012-01-24 Impact factor: 29.983
Authors: François-Pierre Mongeon; Michael Jerosch-Herold; Otávio Rizzi Coelho-Filho; Ron Blankstein; Rodney H Falk; Raymond Y Kwong Journal: JACC Cardiovasc Imaging Date: 2012-09
Authors: Christine Jellis; Jeremy Wright; Dominic Kennedy; Julian Sacre; Carly Jenkins; Brian Haluska; Jennifer Martin; John Fenwick; Thomas H Marwick Journal: Circ Cardiovasc Imaging Date: 2011-09-23 Impact factor: 7.792
Authors: Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong Journal: Circ Cardiovasc Imaging Date: 2013-04-02 Impact factor: 7.792
Authors: Michael F Swartz; Gregory W Fink; Muhammad F Sarwar; George L Hicks; Yao Yu; Rui Hu; Charles J Lutz; Steven M Taffet; José Jalife Journal: J Am Coll Cardiol Date: 2012-10-30 Impact factor: 24.094
Authors: Timothy C Wong; Kayla Piehler; Christopher G Meier; Stephen M Testa; Amanda M Klock; Ali A Aneizi; Jonathan Shakesprere; Peter Kellman; Sanjeev G Shroff; David S Schwartzman; Suresh R Mulukutla; Marc A Simon; Erik B Schelbert Journal: Circulation Date: 2012-07-31 Impact factor: 29.690
Authors: Andrew S Flett; Daniel M Sado; Giovanni Quarta; Mariana Mirabel; Denis Pellerin; Anna S Herrey; Derek J Hausenloy; Cono Ariti; John Yap; Shyam Kolvekar; Andrew M Taylor; James C Moon Journal: Eur Heart J Cardiovasc Imaging Date: 2012-05-25 Impact factor: 6.875
Authors: Jason J Lee; Songtao Liu; Marcelo S Nacif; Martin Ugander; Jing Han; Nadine Kawel; Christopher T Sibley; Peter Kellman; Andrew E Arai; David A Bluemke Journal: J Cardiovasc Magn Reson Date: 2011-11-28 Impact factor: 5.364
Authors: Otavio R Coelho-Filho; François-Pierre Mongeon; Richard Mitchell; Heitor Moreno; Wilson Nadruz; Raymond Kwong; Michael Jerosch-Herold Journal: Circ Cardiovasc Imaging Date: 2012-11-15 Impact factor: 7.792
Authors: Hoshang Farhad; Pedro V Staziaki; Daniel Addison; Otavio R Coelho-Filho; Ravi V Shah; Richard N Mitchell; Balint Szilveszter; Siddique A Abbasi; Raymond Y Kwong; Marielle Scherrer-Crosbie; Udo Hoffmann; Michael Jerosch-Herold; Tomas G Neilan Journal: Circ Cardiovasc Imaging Date: 2016-12 Impact factor: 7.792
Authors: Omar Niss; Robert Fleck; Fowe Makue; Tarek Alsaied; Payal Desai; Jeffrey A Towbin; Punam Malik; Michael D Taylor; Charles T Quinn Journal: Blood Date: 2017-05-15 Impact factor: 22.113
Authors: Charlotte Eitel; Gerhard Hindricks; Matthias Grothoff; Matthias Gutberlet; Philipp Sommer Journal: Curr Cardiol Rep Date: 2014-08 Impact factor: 2.931
Authors: Bharath Ambale-Venkatesh; Chia-Ying Liu; Yuan-Chang Liu; Sirisha Donekal; Yoshiaki Ohyama; Ravi K Sharma; Colin O Wu; Wendy S Post; Gregory W Hundley; David A Bluemke; João A C Lima Journal: Eur Heart J Cardiovasc Imaging Date: 2019-02-01 Impact factor: 6.875
Authors: Ravi V Shah; Siddique A Abbasi; Bobak Heydari; Hoshang Farhad; John A Dodson; Jessie P Bakker; Roy M John; Aristidis Veves; Atul Malhotra; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong; Tomas G Neilan Journal: Am Heart J Date: 2014-01-15 Impact factor: 4.749